Data as of Aug 22
| +0.01 / +0.68%|
The 2 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +240.14% increase from the last price of 1.47.
The current consensus among 2 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.